Combination Strategy Improves Identification of Clinically Significant Prostate Cancers Combination Strategy Improves Identification of Clinically Significant Prostate Cancers

Combining visual-registration and image-fusion biopsy targeting strategies provides the highest rate of detecting clinically significant prostate cancers, according to results from the SmartTarget biopsy trial.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news